Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ramat Gan
Clinical trial register · Israel

Clinical Trials in Ramat Gan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Israel and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2438 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2438
Studies in scope
all four open statuses
1243
Recruiting now
open to new participants
461
Lead sponsors
across recruiting studies
Top sites
Ramat Gan 67 Jerusalem 64 Tel Aviv 53 Haifa 52 Petah Tikva 45
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC86 AbbVie67 Janssen Research & Development, LLC50 AstraZeneca43 Sheba Medical Center30 Clear sponsor filter
Site location
Ramat Gan67 Jerusalem64 Tel Aviv53 Haifa52 Petah Tikva45
All 21 locations
Target enrolment
to

Trials with a site in Ramat Gan

67 of 2438 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Israel
Start
Recruiting
AbbVie
Phase 2
168
Ramat Gan, Jerusalem
2026-08-17
Recruiting
AbbVie
Observational
100
Jerusalem, Ramat Gan, Tel Aviv
2026-08-03
Recruiting
AbbVie
Phase 2/3
900
Ramat Gan, Tel Aviv, Haifa, Jerusalem
2026-04-30
Recruiting
AbbVie
Phase 1
127
Ramat Gan, Tel Aviv, Jerusalem
2026-02-27
Recruiting
AbbVie
Phase 2/3
490
Kefar Sava, Petah Tikva, Tsrifin, Ramat Gan, Haifa
2025-12-10
Recruiting
AbbVie
Phase 2
100
Petah Tikva, Ramat Gan, Tel Aviv, Jerusalem
2025-12-01
Recruiting
AbbVie
Phase 1
285
Ramat Gan, Haifa, Jerusalem
2025-11-27
Recruiting
AbbVie
Phase 2
180
Kefar Sava, Ashdod, Ramat Gan, Haifa, Jerusalem
2025-11-25
Recruiting
AbbVie
Phase 1
220
Ramat Gan, Haifa, Jerusalem
2025-11-20
Recruiting
AbbVie
Phase 3
561
Holon, Petah Tikva, Rehovot, Tsrifin, Ramat Gan, Tel Aviv, Haifa, Jerusalem
2025-11-05
Recruiting
AbbVie
Phase 2/3
854
Petah Tikva, Ramat Gan, Haifa
2025-08-03
Recruiting
AbbVie
Phase 2
377
Petah Tikva, Ramat Gan, Tel Aviv, Haifa, Jerusalem
2025-07-30
Recruiting
AbbVie
Phase 1/2
325
Petah Tikva, Ramat Gan, Tel Aviv, Haifa, Jerusalem
2025-07-23
Recruiting
AbbVie
Phase 1/2
602
Petah Tikva, Beersheba, Ramat Gan, Haifa, Jerusalem
2025-06-30
Active, closed
AbbVie
Phase 3
573
Petah Tikva, Tsrifin, Ashdod, Beersheba, Ramat Gan, Tel Aviv, Haifa
2025-06-17
Recruiting
AbbVie
Observational
1,200
Kfar Saba, Ramat Gan, Tel Aviv, Haifa, Jerusalem, Nahariya
2025-01-31
Active, closed
AbbVie
Phase 1
4
Tsrifin, Jerusalem, Ramat Gan
2025-01-27
Active, closed
AbbVie
Phase 2
150
Kfar Saba, Ramat Gan, Tel Aviv, Haifa, Petah Tikva
2025-01-20
Recruiting
AbbVie
Phase 2
150
Kefar Sava, Petah Tikva, Ramat Gan, Haifa, Jerusalem
2025-01-20
Active, closed
AbbVie
Phase 2
74
Petah Tikva, Haifa, Jerusalem, Ramat Gan, Tel Aviv
2024-11-08
Active, closed
AbbVie
Phase 3
699
Petah Tikva, Afula, Jerusalem, Beersheba, Ramat Gan
2024-08-19
Active, closed
AbbVie
Phase 3
1,400
Petah Tikva, Afula, Nahariya, Ramat Gan, Tel Aviv, Haifa, Jerusalem
2024-06-27
Active, closed
AbbVie
Phase 1
60
Jerusalem, Ramat Gan, Tel Aviv
2024-06-17
Active, closed
AbbVie
Phase 3
421
Petah Tikva, Jerusalem, Ramat Gan, Tel Aviv
2024-05-19
Active, closed
AbbVie
Phase 2
156
Tsrifin, Jerusalem, Beersheba, Ramat Gan, Tel Aviv, Petah Tikva
2024-03-23
Active, closed
AbbVie
Phase 1
152
Ramat Gan, Haifa, Jerusalem
2024-03-08
Active, closed
AbbVie
Observational
427
Jerusalem, Ramat Gan, Tel Aviv, Haifa, Petah Tikva
2024-01-24
Active, closed
AbbVie
Phase 3
614
Petah Tikva, Jerusalem, Ramat Gan, Tel Aviv, Haifa
2023-12-19
Active, closed
AbbVie
Phase 3
289
Jerusalem, Ramat Gan, Haifa
2023-11-15
Active, closed
AbbVie
Phase 2
280
Kfar Saba, Jerusalem, Ramat Gan, Tel Aviv, Haifa
2023-11-12
Recruiting
AbbVie
Phase 1
325
Petah Tikva, Ramat Gan, Tel Aviv, Haifa, Jerusalem
2023-11-09
Recruiting
AbbVie
Phase 3
1,500
Petah Tikva, Jerusalem, Ramat Gan, Tel Aviv, Haifa
2023-10-11
Active, closed
AbbVie
Phase 3
1,014
Kfar Saba, Jerusalem, Nahariya, Ramat Gan, Tel Aviv, Haifa
2023-07-25
Active, closed
AbbVie
Phase 3
1,328
Petah Tikva, Safed, Ramat Gan, Tel Aviv, Haifa
2023-06-21
Active, closed
AbbVie
Observational
1,019
Jerusalem, Ramat Gan, Tel Aviv, Petah Tikva
2023-06-09
Active, closed
AbbVie
Phase 1
135
Tsrifin, Jerusalem, Ramat Gan, Tel Aviv
2023-06-09
By invitation
AbbVie
Phase 3
650
Beer Ya'akov, Hadera, Haifa, Ramat Gan, Tel Aviv
2023-06-05
Recruiting
AbbVie
Phase 3
450
Beer Ya'akov, Hadera, Ramat Gan, Tel Aviv, Haifa
2023-05-01
Active, closed
AbbVie
Phase 1
39
Ramat Gan, Jerusalem
2023-04-26
Active, closed
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
NCT05618028Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, B Cell Malignancies, Non-Hodgkin's Lymphoma
AbbVie
Phase 1
78
Beer Ya'akov, Petah Tikva, Jerusalem, Ramat Gan
2023-04-04
Recruiting
AbbVie
Phase 1
210
Petah Tikva, Jerusalem, Ramat Gan, Tel Aviv
2023-03-21
Active, closed
AbbVie
Phase 3
520
Holon, Kfar Saba, Petah Tikva, Rehovot, Ramat Gan, Tel Aviv, Haifa, Jerusalem
2023-03-15
Active, closed
AbbVie
Phase 1
288
Ramat Gan, Haifa, Jerusalem
2022-12-05
Active, closed
AbbVie
Phase 1
34
Jerusalem, Ramat Gan, Tel Aviv
2022-05-17
Recruiting
AbbVie
Phase 2
75
Jerusalem, Ramat Gan, Tel Aviv, Petah Tikva
2022-03-28
Recruiting
AbbVie
Phase 1
694
Beer Ya'akov, Kefar Sava, Petah Tikva, Ramat Gan, Tel Aviv, Haifa, Jerusalem
2021-11-01
Active, closed
AbbVie
Phase 1
520
Kfar Saba, Jerusalem, Ramat Gan, Tel Aviv, Haifa, Petah Tikva
2021-10-13
Active, closed
AbbVie
Observational
141
Rehovot, Afula, Jerusalem, Safed, Ashkelon, Beersheba, Ramat Gan, Tel Aviv
2021-04-26
Active, closed
AbbVie
Phase 1
81
Haifa, Ramat Gan
2021-02-23
Active, closed
AbbVie
Phase 1
21
Jerusalem, Ramat Gan, Tel Aviv
2020-11-11
Active, closed
AbbVie
Phase 3
527
Tsrifin, Jerusalem, Ashkelon, Beersheba, Ramat Gan, Tel Aviv, Petah Tikva
2020-09-30
Active, closed
AbbVie
Phase 3
531
Jerusalem, Ramat Gan, Tel Aviv, Haifa, Petah Tikva
2020-09-10
Active, closed
AbbVie
Phase 3
330
Tsrifin, Afula, Haifa, Jerusalem, Nahariya, Ashdod, Ramat Gan, Tel Aviv
2020-08-31
Active, closed
AbbVie
Observational
100
Kfar Saba, Tel Aviv, Afula, Jerusalem, Safed, Beersheba, Ramat Gan, Haifa
2019-08-08
Active, closed
AbbVie
Phase 1
124
Ramat Gan
2019-06-24
Active, closed
AbbVie
Phase 1
150
Ramat Gan
2019-05-21
Active, closed
AbbVie
Phase 3
964
Ramat Gan, Ashkelon, Haifa, Kfar Saba, Petah Tikva
2019-03-25
Active, closed
AbbVie
Phase 1
364
Haifa, Ramat Gan, Tel Aviv, Jerusalem, Petah Tikva
2019-02-21
Active, closed
AbbVie
Phase 3
265
Haifa, Jerusalem, Ashdod, Beersheba, Ramat Gan, Tel Aviv, Petah Tikva
2018-10-22
Active, closed
AbbVie
Phase 2
270
Kfar Saba, Beersheba, Ramat Gan, Haifa, Petah Tikva
2018-10-10
Active, closed
AbbVie
Phase 3
1,242
Jerusalem, Beersheba, Ramat Gan, Haifa, Petah Tikva
2018-08-28
Active, closed
AbbVie
Phase 3
1,533
Beersheba, Ramat Gan, Tel Aviv, Afula, Petah Tikva
2018-08-09
Active, closed
AbbVie
Phase 3
1,336
Jerusalem, Beersheba, Holon, Ramat Gan, Tel Aviv, Haifa
2018-04-09
Active, closed
AbbVie
Phase 3
443
Ramat Gan, Tel Aviv, Be’er Ya‘aqov, Haifa, Jerusalem, Petah Tikva
2017-02-02
Active, closed
AbbVie
Phase 3
1,629
Tel Aviv, Haifa, Ramat Gan
2015-12-01
Active, closed
AbbVie
Observational
1,446
Petah Tikva, Rehovot, Tsrifin, Jerusalem, Ramat Gan, Afula, Haifa
2014-08-28
Active, closed
AbbVie
Observational
8,250
Kfar Saba, Tsrifin, Hadera, Jerusalem, Ramat Gan, Haifa, Kiriat Bialik, Lower Galilee
2013-04-29
Rows per page Showing 1–67 of 67
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Israeli investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-israel/city/ramat-gan

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Israel and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,438 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 67 of those studies with a site in Ramat Gan that also match the filters currently applied.

How many clinical trials are recruiting in Ramat Gan?

22 of the 67 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 44 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ramat Gan), 67 studies
PhaseStudiesRecruitingShare
Phase 323334.3%
Phase 120629.9%
Phase 211616.4%
Observational8211.9%
Phase 2/3334.5%
Phase 1/2223%

Most active sponsors

Lead sponsors with the most studies (Ramat Gan)
Lead sponsorStudiesRecruiting
AbbVie6722
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.